Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Stephanie Dakin, an Arthritis Research UK Fellow at NDORMS, has been interviewed by the BBC about her work exploring the treatment of tendon injuries in humans, which builds on her significant experience working with horses.

Dr Stephanie Dakin, an Arthritis Research UK Fellow at NDORMS, is exploring the treatment of tendon injuries in humans building on her significant experience working with horses. She was interviewed this week by the BBC and explains:

Horses are highly evolved to run efficiently. The tendons in their lower limbs function as energy storing springs enabling them to move quickly in an almost passive manner. One disadvantage of this is that these tendons operate very closely to their functional limits, therefore athletic horses are highly prone to developing tendon injuries.

Tendon injuries in horses and humans occur due to a combination of factors including the effects of ageing, repetitive exercise and inflammation. This makes the horse an excellent model of studying tendon pathology in humans. Tendon injuries in both horses and humans are difficult to treat, require prolonged rehabilitation and heal by the formation of scar tissue which is prone to re-injury.

Findings from studying tendon injuries in horses are currently being advanced and translated to help human patients with tendon injuries. It is hoped that the current Arthritis Research UK funded work at the Botnar Research Centre will help to identify new therapies to treat Achilles and rotator cuff tendinopathy in the future. Our goal is to advance this under-researched area of tendon healing so that both human and equine patients can benefit from this research.

The video above has been kindly provided by BBC Oxford to help explain the work that is being done. It can be temporarily viewed at higher quality on the BBC iPlayer service.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.